Back to today’s briefing

Story perspectives

WHO to Endorse GLP-1s to Combat Global Obesity Crisis

5/2/2025

50 6

Summary

Story summary

The World Health Organization (WHO) is set to endorse weight-loss medications, particularly GLP-1s like Wegovy and Zepbound, to tackle the global obesity crisis. This initiative seeks to enhance access in low- and middle-income countries, home to over a billion affected individuals. Final recommendations are expected by August 2025, focusing on affordability and chronic care integration.

1 of 1

Story summary

The World Health Organization (WHO) is set to endorse weight-loss medications, particularly GLP-1s like Wegovy and Zepbound, to tackle the global obesity crisis. This initiative seeks to enhance access in low- and middle-income countries, home to over a billion affected individuals. Final recommendations are expected by August 2025, focusing on affordability and chronic care integration.